Compare Graham Holdings Company Common Stock (GHC) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,186.01 (market cap $5.02B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Graham Holdings Company Common Stock and Oruka Therapeutics Inc. Common Stock are close in size by market cap, and Graham Holdings Company Common Stock pays a 0.63% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| GHC | ORKA | |
|---|---|---|
Market Cap | $5.02B | $5.08B |
Volume | 21,118 | 685,276 |
Sector | Industrials | Health |
52-Week High | $1.23K | $113.08 |
52-Week Low | $949.84 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.12B | $4.21B |
Dividend Yield | 0.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
